Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol

Virological Suppression in HIV Positive Patients Involved in a Novel, Standardized Adherence Protocol

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03517358

Enrollment

Registered

2018-05-07

Start date

2018-01-01

Completion date

2018-05-01

Last updated

2020-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv

Brief summary

This study will look at virologically suppression of patients with HIV who receive pharmacist or case management care.

Interventions

OTHERService of care

Subjects will be receiving care from case management or clinical pharmacy.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients with a baseline viral load \> 200 copies/ml * Patients who agree to program enrollment * Patients ≥ 18 years of age

Exclusion criteria

* Pregnant women * Adults unable to consent * Prisoners

Design outcomes

Primary

Measure	Time frame
Percentage of virological suppression	6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026